These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21247167)

  • 41. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
    Bennett KA; Christopher JA; Tehan BG
    Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
    Stansley BJ; Conn PJ
    Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery, Structure-Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4.
    Charvin D; Pomel V; Ortiz M; Frauli M; Scheffler S; Steinberg E; Baron L; Deshons L; Rudigier R; Thiarc D; Morice C; Manteau B; Mayer S; Graham D; Giethlen B; Brugger N; Hédou G; Conquet F; Schann S
    J Med Chem; 2017 Oct; 60(20):8515-8537. PubMed ID: 28902994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator.
    Rosenbrock H; Kramer G; Hobson S; Koros E; Grundl M; Grauert M; Reymann KG; Schröder UH
    Eur J Pharmacol; 2010 Aug; 639(1-3):40-6. PubMed ID: 20371241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).
    Gogliotti RD; Blobaum AL; Morrison RM; Daniels JS; Salovich JM; Cheung YY; Rodriguez AL; Loch MT; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2016 Jul; 26(13):2984-2987. PubMed ID: 27234146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4.
    Volpi C; Fallarino F; Mondanelli G; Macchiarulo A; Grohmann U
    Expert Opin Drug Discov; 2018 May; 13(5):411-423. PubMed ID: 29486616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄.
    Cheung YY; Zamorano R; Blobaum AL; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    ACS Comb Sci; 2011 Mar; 13(2):159-65. PubMed ID: 21338051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G; Broad LM; Wafford KA; Britton T; Colvin EM; Fivush A; Gastambide F; Getman B; Heinz BA; McCarthy AP; Prieto L; Shanks E; Smith JW; Taboada L; Edgar DM; Tricklebank MD
    Neuropharmacology; 2013 Jan; 64():224-39. PubMed ID: 22884720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.
    Johnson KA; Lovinger DM
    Adv Pharmacol; 2020; 88():193-232. PubMed ID: 32416868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lead optimization of the VU0486321 series of mGlu
    Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW
    Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.
    Hikichi H; Murai T; Okuda S; Maehara S; Satow A; Ise S; Nishino M; Suzuki G; Takehana H; Hata M; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):106-14. PubMed ID: 20371227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics.
    Garcia-Barrantes PM; Cho HP; Niswender CM; Byers FW; Locuson CW; Blobaum AL; Xiang Z; Rook JM; Conn PJ; Lindsley CW
    J Med Chem; 2015 Oct; 58(20):7959-71. PubMed ID: 26426481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor.
    Bradley SJ; Watson JM; Challiss RA
    Mol Pharmacol; 2009 Dec; 76(6):1302-13. PubMed ID: 19737913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.
    Williams R; Manka JT; Rodriguez AL; Vinson PN; Niswender CM; Weaver CD; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1350-3. PubMed ID: 21315585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs).
    Szabó G; Kolok S; Orgován Z; Vastag M; Béni Z; Kóti J; Sághy K; Lévay GI; Greiner I; Keserű GM
    Eur J Med Chem; 2020 Jan; 186():111881. PubMed ID: 31780081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.
    Gregory KJ; Dong EN; Meiler J; Conn PJ
    Neuropharmacology; 2011 Jan; 60(1):66-81. PubMed ID: 20637216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
    Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.